友邦(1299.HK)漲超3%帶動恆指漲超百點 收購東亞人壽 與東亞銀行達成15年獨家分銷合作
格隆匯3月25日丨友邦保險(1299.HK)高開高走,現報96.25港元,漲3.77%,帶動恆指漲超100點,暫成交8億港元,最新總市值1.16萬億港元。友邦昨日晚間發公吿稱,與東亞銀行達成為其15年、覆蓋香港及中國內地的獨家策略性銀行保險夥伴協議。東亞銀行將向其零售銀行客户獨家分銷友邦保險的人壽保險產品及長期儲蓄產品。公吿顯示,友邦保險為該項分銷合作協議及收購東亞銀行全資子所有的東亞人壽保險全數股權,支付50.7億港元(約合6.5億美元)。此外,友邦保險將收購藍十字(亞太)保險過往承保的人壽保單業務。友邦稱,選擇東亞銀行為策略分銷夥伴,將進一步加強友邦保險在粵港澳大灣區的優勢。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.